Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Harmon Cyrus
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-29
Sale
2021-12-01
5:34 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
400$24.76$9,9041,173,174
(Indirect
Direct)
View
2021-10-19
Sale
2021-10-21
4:33 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
12,000$27.98$335,7941,173,574
(Indirect
Direct)
View
2021-09-20
Sale
2021-09-21
6:19 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
12,000$26.3$315,6001,185,574
(Indirect
Direct)
View
2021-08-19
Sale
2021-08-20
9:14 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
12,000$24.97$299,6401,197,574
(Indirect
Direct)
View
2021-07-20
Sale
2021-07-21
5:29 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
12,000$25.1$301,2581,209,574
(Indirect
Direct)
View
2021-06-18
Sale
2021-06-21
7:05 pm
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
12,000$24.8$297,6261,099,546
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-01
Option Award
2022-02-03
7:10 pm
N/A
2032-01-31
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
CHIEF TECHNOLOGY OFFICER
104,500$0104,500
(Direct)
View
2020-11-23
Conversion
2020-11-23
4:31 pm
N/A
N/A
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
Chief Technology Officer
193,402$01,233,574
(Direct)
View
2020-11-18(A)
Option Award
2020-11-20
6:42 pm
N/A
2030-11-17
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
Chief Technology Officer
1,076$01,076
(Indirect)
View
2020-06-15
Option Award
2020-11-19
6:43 pm
N/A
2030-09-11
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
Chief Technology Officer
550,671$01,447,371
(Direct)
View
2020-11-18
Ownership
2020-11-18
6:19 pm
N/A
N/A
Olema Pharmaceuticals Inc.OLMAHarmon Cyrus
Chief Technology Officer
0$01,461,433
(Direct)
View
(A) Indicate amendment filing.